| Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The lancet 399 (10325), 629-655, 2022 | 7500 | 2022 |
| Tenofovir versus placebo to prevent perinatal transmission of hepatitis B G Jourdain, N Ngo-Giang-Huong, L Harrison, L Decker, W Khamduang, ... New England Journal of Medicine 378 (10), 911-923, 2018 | 306 | 2018 |
| Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update TR Cressey, M Lallemant Infection, genetics and evolution 7 (2), 333-342, 2007 | 107 | 2007 |
| Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum TR Cressey, A Stek, E Capparelli, C Bowonwatanuwong, S Prommas, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (3), 245-252, 2012 | 106 | 2012 |
| Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to … TR Cressey, G Jourdain, MJ Lallemant, S Kunkeaw, JB Jackson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 38 (3), 283-288, 2005 | 102 | 2005 |
| Raltegravir pharmacokinetics during pregnancy DH Watts, A Stek, BM Best, J Wang, EV Capparelli, TR Cressey, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 67 (4), 375-381, 2014 | 75 | 2014 |
| Dolutegravir as first-or second-line treatment for HIV-1 infection in children A Turkova, E White, HA Mujuru, AR Kekitiinwa, CM Kityo, A Violari, ... New England Journal of Medicine 385 (27), 2531-2543, 2021 | 72 | 2021 |
| Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network G Li, JA Bielicki, ASMNU Ahmed, MS Islam, EN Berezin, CB Gallacci, ... Archives of disease in childhood 105 (1), 26-31, 2020 | 66 | 2020 |
| Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine K Chokephaibulkit, N Plipat, TR Cressey, K Frederix, W Phongsamart, ... Aids 19 (14), 1495-1499, 2005 | 64 | 2005 |
| Brief report: validation of a urine tenofovir immunoassay for adherence monitoring to PrEP and ART and establishing the cutoff for a point-of-care test M Gandhi, P Bacchetti, MA Spinelli, H Okochi, JM Baeten, O Siriprakaisil, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 81 (1), 72-77, 2019 | 63 | 2019 |
| Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women A Stek, BM Best, J Wang, EV Capparelli, SK Burchett, R Kreitchmann, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (1), 33-41, 2015 | 59 | 2015 |
| Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand G Jourdain, S Le Cœur, N Ngo-Giang-Huong, P Traisathit, TR Cressey, ... PLoS medicine 10 (8), e1001494, 2013 | 57 | 2013 |
| Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings M Gandhi, G Wang, R King, WC Rodrigues, M Vincent, DV Glidden, ... Aids 34 (2), 255-260, 2020 | 53 | 2020 |
| Plasma efavirenz concentrations and the association with CYP2B6-516 G >T polymorphism in HIV-infected Thai children T Puthanakit, P Tanpaiboon, L Aurpibul, TR Cressey, V Sirisanthana Antiviral therapy 14 (3), 315-320, 2009 | 51 | 2009 |
| Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV‐1 infected Thai adults C Sukasem, TR Cressey, P Prapaithong, Y Tawon, E Pasomsub, ... British journal of clinical pharmacology 74 (6), 1005-1012, 2012 | 47 | 2012 |
| Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand F Fregonese, IJ Collins, G Jourdain, S LeCoeur, TR Cressey, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 60 (1), 91-98, 2012 | 47 | 2012 |
| Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children IMPAACT P1069 Team, K Chokephaibulkit, TR Cressey, E Capparelli, ... Antiviral therapy 16 (8), 1287-1295, 2011 | 45 | 2011 |
| Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy R Kreitchmann, BM Best, J Wang, A Stek, E Caparelli, DH Watts, E Smith, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 63 (1), 59-66, 2013 | 44 | 2013 |
| Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected Thai children TR Cressey, L Aurpibul, T Narkbunnam, V Sirisanthana, W Phongsamart, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (1), e27-e29, 2013 | 44 | 2013 |
| Pharmacokinetic optimization of antiretroviral therapy in pregnancy K Buckoreelall, TR Cressey, JR King Clinical pharmacokinetics 51, 639-659, 2012 | 44 | 2012 |
